Referencias+Bibliográficas+Secreción+de+Glucagón


 * REFERENCIAS **


 * Ahloulay M, Bouby N, Machet F, Kubrusly M, Coutaud C & Bankir L 1992 Effects of glucagon on glomerular filtration rate and urea and water excretion. American Journal of Physiology. Renal Physiology 263 F24–F36.
 * Ahren B 2000 Autonomic regulation of islet hormone secretion – implications for health and disease. Diabetologia 43 393–410.
 * Ahren B & Lundquist I 1982 Influences of gastro-intestinal polypeptides and glucose on glucagon secretion induced by cholinergic stimulation. Hormone and Metabolic Research 14 529–532.
 * Ahren B, Veith RC & Taborsky GJ Jr 1987 Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 1). Effects on basal release of insulin and glucagon. Endocrinology 121 323–331.
 * Akesson B, Panagiotidis G, Westermark P & Lundquist I 2003 Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets. Regulatory Peptides 111 55–60.
 * Andersen B, Rassov A, Westergaard N & Lundgren K 1999 Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino- D-arabinitol. Biochemical Journal 342 545–550.
 * Andrews SS, Lopez-S A & Blackard WG 1975 Effect of lipids on glucagon secretion in man. Metabolism 24 35–44.
 * Asplin C, Raghu P, Dornan T & Palmer JP 1983 Glucose regulation of glucagon secretion independent of B cell activity. Metabolism 32 292–295.
 * Bailey SJ, Ravier MA & Rutter GA 2007 Glucose-dependent regulation of gamma-aminobutyric acid (GABA A) receptor expression in mouse pancreatic islet alpha-cells. Diabetes 56 320–327.
 * Balkan B & Li X 2000 Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 279 R1449–R1454.
 * Band GC & Jones CT 1980 Functional activation by glucagon of glucose 6-phosphatase and gluconeogenesis in the perfused liver of the fetal guinea pig. FEBS Letters 119 190–194.
 * Barg S, Galvanovskis J, Gopel SO, Rorsman P & Eliasson L 2000 Tight coupling between electrical activity and exocytosis in mouse glucagon- secreting alpha-cells. Diabetes 49 1500–1510.
 * Baron AD, Schaeffer L, Shragg P & Kolterman OG 1987 Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes 36 274–283.
 * Bertrand G, Gross R, Puech R, Loubatieres-Mariani MM & Bockaert J 1993 Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. European Journal of Pharmacology 237 45–50.
 * Berts A, Gylfe E & Hellman B 1997 Cytoplasmic Ca2C in glucagon- producing pancreatic alpha-cells exposed to carbachol and agents affecting NaC fluxes. Endocrine 6 79–83.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Bohannon NV, Lorenzi M, Grodsky GM & Karam JH 1982 Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects. Journal of Clinical Endocrinology and Metabolism 54 459–462.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Bokvist K, Olsen HL, Hoy M, Gotfredsen CF, Holmes WF, Buschard K, Rorsman P & Gromada J 1999 Characterisation of sulphonylurea and ATP- regulated KC channels in rat pancreatic A-cells. Pflugers Archiv: European Journal of Physiology 438 428–436.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Bollheimer LC, Landauer HC, Troll S, Schweimer J, Wrede CE, Scholmerich J & Buettner R 2004 Stimulatory short-term effects of free fatty acids on glucagon secretion at low to normal glucose concentrations. Metabolism 53 1443–1448.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Bolli GB, Tsalikian E, Haymond MW, Cryer PE & Gerich JE 1984 Defective glucose counterregulation after subcutaneous insulin in noninsulin- dependent diabetes mellitus.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions. Journal of Clinical Investigation 73 1532–1541.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Bonner-Weir S 1991 Anatomy of the islet of Langerhans. In The Endocrine Pancreas, pp 15–28. Ed. E Samols. New York: Raven Press.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML & Shulman GI 1994 Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. Journal of Clinical Investigation 93 1677–1682.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Brelje TC, Scharp DW & Sorenson RL 1989 Three-dimensional imaging of intact isolated islets of Langerhans with confocal microscopy. Diabetes 38 808–814.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM & Powers AC 2005 Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. Journal of Histochemistry and Cytochemistry 53 1087–1097.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO & Caicedo A 2006 The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. PNAS 103 2334–2339.
 * <span style="font-family: 'Century Gothic',sans-serif;">Cabrera O, Jacques-Silva MC, Speier S, Yang SN, Ko <span style="font-family: 'Cambria Math',serif;">̈ <span style="font-family: 'Century Gothic',sans-serif;">hler M, Fachado A, Vieira E, Zierath JR, Kibbey R, Berman DM et al. 2008 Glutamate is a positive autocrine signal for glucagon release. Cell Metabolism 7 545–554.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Carlson MG, Snead WL & Campbell PJ 1993 Regulation of free fatty acid metabolism by glucagon. Journal of Clinical Endocrinology and Metabolism 77 11–15.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Chastain MA 2001 The glucagonoma syndrome: a review of its features and discussion of new perspectives. American Journal of the Medical Sciences 321 306–320.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Ciudad C, Camici M, Ahmad Z, Wang Y, DePaoli-Roach AA & Roach PJ 1984 Control of glycogen synthase phosphorylation in isolated rat hepatocytes by epinephrine, vasopressin and glucagon. European Journal of Biochemistry 142 511–520.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Consoli A, Nurjhan N, Capani F & Gerich J 1989 Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38 550–557.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Cryer PE 2002 Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 45 937–948.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Cynober LA 2002 Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 18 761–766.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Dallas-Yang Q, Shen X, Strowski M, Brady E, Saperstein R, Gibson RE, Szalkowski D, Qureshi SA, Candelore MR, Fenyk-Melody JE et al. 2004 Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists. European Journal of Pharmacology 501 225–234.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Degn KB, Brock B, Juhl CB, Djurhuus CB, Grubert J, Kim D, Han J, Taylor K, Fineman M & Schmitz O 2004 Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia. Diabetes 53 2397–2403.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Detimary P, Dejonghe S, Ling Z, Pipeleers D, Schuit F & Henquin JC 1998 The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in beta cells but not in alpha cells and are also observed in human islets. Journal of Biological Chemistry 273 33905–33908.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Dey A, Lipkind GM, Rouille Y, Norrbom C, Stein J, Zhang C, Carroll R & Steiner DF 2005 Significance of prohormone convertase 2, PC2, mediated initial cleavage at the proglucagon interdomain site, Lys70-Arg71, to generate glucagon. Endocrinology 146 713–727.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Diao J, Asghar Z, Chan CB & Wheeler MB 2005 Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic a-cells. Journal of Biological Chemistry 280 33487–33496.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Ding WG, Renstrom E, Rorsman P, Buschard K & Gromada J 1997 Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2C-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism. Diabetes 46 792–800.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Dinneen S, Alzaid A, Turk D & Rizza R 1995 Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia 38 337–343.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Dumonteil E, Magnan C, Ritz-Laser B, Meda P, Dussoix P, Gilbert M, Ktorza A & Philippe J 1998 Insulin, but not glucose lowering corrects the hyperglucagonemia and increased proglucagon messenger ribonucleic acid levels observed in insulinopenic diabetes. Endocrinology 139 4540–4546.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Dumonteil E, Ritz-Laser B, Magnan C, Grigorescu I, Ktorza A & Philippe J 1999 Chronic exposure to high glucose concentrations increases proglucagon messenger ribonucleic acid levels and glucagon release from InR1G9 cells. Endocrinology 140 4644–4650.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Dumonteil E, Magnan C, Ritz-Laser B, Ktorza A, Meda P & Philippe J 2000 Glucose regulates proinsulin and prosomatostatin but not proglucagon messenger ribonucleic acid levels in rat pancreatic islets. Endocrinology 141 174–180.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Dunning BE & Gerich JE 2007 The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocrine Reviews 28 253–283.
 * <span style="font-family: 'Century Gothic',sans-serif;">Dunning BE, Foley JE & Ahre ́ <span style="font-family: 'Century Gothic',sans-serif;">n B 2005 Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 48 1700–1713. Eledrisi MS, Alshanti MS, Shah MF, Brolosy B & Jaha N 2006 Overview of <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">the diagnosis and management of diabetic ketoacidosis. American Journal of the Medical Sciences 331 243–251.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Fehmann HC, Strowski M & Goke B 1995 Functional characterization of somatostatin receptors expressed on hamster glucagonoma cells. American Journal of Physiology. Endocrinology and Metabolism 268 E40–E47.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Franklin I, Gromada J, Gjinovci A, Theander S & Wollheim CB 2005 b-cell secretory products activate a-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 54 1808–1815.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Furuta M, Zhou A, Webb G, Carroll R, Ravazzola M, Orci L & Steiner DF 2001 Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. Journal of Biological Chemistry 276 27197–27202.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, Landau BR & Ferrannini E 2000 Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49 1367–1373.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gedulin BR, Jodka CM, Herrmann K & Young AA 2006 Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187. Regulatory Peptides 137 121–127.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gelling RW, Du XQ, Dichmann DS, Romer J, Huang H, Cui L, Obici S, Tang B, Holst JJ, Fledelius C et al. 2003 Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. PNAS 100 1438–1443.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gopel S, Kanno T, Barg S, Galvanovskis J & Rorsman P 1999 Voltage-gated and resting membrane currents recorded from b-cells in intact mouse pancreatic islets. Journal of Physiology 521 717–728.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gopel SO, Kanno T, Barg S & Rorsman P 2000 Patch-clamp characterisation of somatostatin-secreting delta-cells in intact mouse pancreatic islets. Journal of Physiology 528 497–507.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gorus FK, Malaisse WJ & Pipeleers DG 1984 Differences in glucose handling by pancreatic A- and B-cells. Journal of Biological Chemistry 259 1196–1200.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Grapengiesser E, Salehi A, Qader SS & Hellman B 2006 Glucose induces glucagon release pulses antisynchronous with insulin and sensitive to purinoceptor inhibition. Endocrinology 147 3472–3477.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gravholt CH, Moller N, Jensen MD, Christiansen JS & Schmitz O 2001 Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis. Journal of Clinical Endocrinology and Metabolism 86 2085–2089.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gremlich S, Bonny C, Waeber G & Thorens B 1997 Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. Journal of Biological Chemistry 272 30261–30269.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gromada J, Bokvist K, Ding WG, Barg S, Buschard K, Renstrom E & Rorsman P 1997 Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2C current and the number of granules close to the L-type Ca2C channels. Journal of General Physiology 110 217–228.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gromada J, Hoy M, Buschard K, Salehi A & Rorsman P 2001 Somatostatin inhibits exocytosis in rat pancreatic a-cells by Gi2-dependent activation of calcineurin and depriming of secretory granules. Journal of Physiology 535 519–532.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gromada J, Ma X, Hoy M, Bokvist K, Salehi A, Berggren PO & Rorsman P 2004 ATP-sensitive KC channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1K/K mouse alpha-cells. Diabetes 53 (Suppl 3) S181–S189.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gromada J, Franklin I & Wollheim CB 2007 Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocrine Reviews 28 84–116.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Guenifi A, Ahren B & Abdel-Halim SM 2001 Differential effects of glucagon- like peptide-1 (7–36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro. Pancreas 22 58–64.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Gyulkhandanyan AV, Lu H, Lee SC, Bhattacharjee A, Wijesekara N, Fox JE, MacDonald PE, Chimienti F, Dai FF & Wheeler MB 2008 Investigation of transport mechanisms and regulation of intracellular Zn2C in pancreatic a-cells. Journal of Biological Chemistry 283 10184–10197.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Hayashi M, Otsuka M, Morimoto R, Muroyama A, Uehara S, Yamamoto A & Moriyama Y 2003a Vesicular inhibitory amino acid transporter is present in glucagon-containing secretory granules in alphaTC6 cells, mouse clonal alpha-cells, and alpha-cells of islets of Langerhans. Diabetes 52 2066–2074.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Hayashi M, Yamada H, Uehara S, Morimoto R, Muroyama A, Yatsushiro S, Takeda J, Yamamoto A & Moriyama Y 2003b Secretory granule-mediated co-secretion of L-glutamate and glucagon triggers glutamatergic signal transmission in islets of Langerhans. Journal of Biological Chemistry 278 1966–1974.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Heimberg H, De Vos A, Pipeleers D, Thorens B & Schuit F 1995 Differences in glucose transporter gene expression between rat pancreatic alpha- and beta-cells are correlated to differences in glucose transport but not in glucose utilization. Journal of Biological Chemistry 270 8971–8975.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Heimberg H, De Vos A, Moens K, Quartier E, Bouwens L, Pipeleers D, Van Schaftingen E, Madsen O & Schuit F 1996 The glucose sensor protein glucokinase is expressed in glucagon-producing alpha a-cells. PNAS 93 7036–7041.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P et al. 2001 CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413 179–183.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Hjorth SA, Adelhorst K, Pedersen BB, Kirk O & Schwartz TW 1994 Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes. Journal of Biological Chemistry 269 30121–30124.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Hong J, Abudula R, Chen J, Jeppesen PB, Dyrskog SEU, Xiao J, Colombo M & Hermansen K 2005 The short-term effect of fatty acids on glucagon secretion is influenced by their chain length, spatial configuration, and degree of unsaturation: studies in vitro. Metabolism 54 1329–1336.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Hong J, Jeppesen PB, Nordentoft I & Hermansen K 2007 Fatty acid-induced effect on glucagon secretion is mediated via fatty acid oxidation. Diabetes/Metabolism Research and Reviews 23 202–210.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Hoy M, Bokvist K, Xiao-Gang W, Hansen J, Juhl K, Berggren PO, Buschard K & Gromada J 2001 Phentolamine inhibits exocytosis of glucagon by Gi2 protein-dependent activation of calcineurin in rat pancreatic alpha-cells. Journal of Biological Chemistry 276 924–930.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Hunyady B, Hipkin RW, Schonbrunn A & Mezey E 1997 Immunohisto- chemical localization of somatostatin receptor SST2A in the rat pancreas. Endocrinology 138 2632–2635.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Inagaki N, Kuromi H, Gonoi T, Okamoto Y, Ishida H, Seino Y, Kaneko T, Iwanaga T & Seino S 1995 Expression and role of ionotropic glutamate receptors in pancreatic islet cells. FASEB Journal 9 686–691.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Ishihara H, Maechler P, Gjinovci A, Herrera PL & Wollheim CB 2003 Islet beta-cell secretion determines glucagon release from neighbouring alpha- cells. Nature Cell Biology 5 330–335.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Juhl CB, Hollingdal M, Sturis J, Jakobsen G, Agerso H, Veldhuis J, Porksen N & Schmitz O 2002 Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. Diabetes 51 424–429.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Kaneko K, Shirotani T, Araki E, Matsumoto K, Taguchi T, Motoshima H, Yoshizato K, Kishikawa H & Shichiri M 1999 Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells. Diabetes Research and Clinical Practice 44 83–92.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Kendall DM, Poitout V, Olson LK, Sorenson RL & Robertson RP 1995 Somatostatin coordinately regulates glucagon gene expression and exocytosis in HIT-T15 cells. Journal of Clinical Investigation 96 2496–2502.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Kuhara T, Ikeda S, Ohneda A & Sasaki Y 1991 Effects of intravenous infusion of 17 amino acids on the secretion of GH, glucagon, and insulin in sheep. American Journal of Physiology. Endocrinology and Metabolism 260 E21–E26.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, Patel SC & Patel YC 1999 Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes 48 77–85.
 * <span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, Patel SC & Patel YC 1999 Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes 48 77–85.

<span style="font-family: 'Century Gothic',sans-serif; font-size: 120%;">